The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® ...
Stopping cancer cells from entering a soft biomechanical state could help the immune system clear dormant cancer metastasis.
Saudi Gazette on MSN
SFDA approves registration of 'Anktiva' for treatment of bladder and lung cancer
The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in ...
Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...
During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...
Bone metastases from pancreatic tumors are rare, representing less than 5% of all metastases [ 2 ]. Among these, only three ...
Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...
Enhanced chemosensitivity: Laboratory data suggest PRP makes resistant pancreatic tumor cells more responsive to standard chemotherapies and alters the tumor microenvironment — including reduced ...
Metastasis-directed stereotactic radiotherapy alongside biological cancer therapy appears safe, new data show.
New Memorial Sloan Kettering Cancer Center research reveals how dormant metastatic cancer cells protect themselves from the ...
Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...
Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback